United States · FDA National Drug Code directory
TERBINAFINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62135-572_2659c503-319a-b899-e063-6294a90aa6a6
- Product NDC
- 62135-572
- Form
- TABLET
- Composition / generic term
- Terbinafine
- Labeler
- Chartwell RX, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070702
- Source listing expiry
- 20261231
Source-listed ingredients
- TERBINAFINE HYDROCHLORIDE — 250 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (62135-572-30) · 62135-572-30
- 90 TABLET in 1 BOTTLE (62135-572-90) · 62135-572-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →